These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29954667)

  • 1. Efficacy and adverse effects of sotalol in adults with congenital heart disease.
    Moore BM; Cordina RL; McGuire MA; Celermajer DS
    Int J Cardiol; 2019 Jan; 274():74-79. PubMed ID: 29954667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of amiodarone therapy in adults with congenital heart disease.
    Moore BM; Cordina RL; McGuire MA; Celermajer DS
    Congenit Heart Dis; 2018 Nov; 13(6):944-951. PubMed ID: 30239160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
    Miyazaki A; Ohuchi H; Kurosaki K; Kamakura S; Yagihara T; Yamada O
    Circ J; 2008 Dec; 72(12):1998-2003. PubMed ID: 18931451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical safety profile of sotalol in the treatment of arrhythmias.
    MacNeil DJ; Davies RO; Deitchman D
    Am J Cardiol; 1993 Aug; 72(4):44A-50A. PubMed ID: 8346726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.
    Rao SO; Boramanand NK; Burton DA; Perry JC
    Int J Cardiol; 2009 Aug; 136(3):253-7. PubMed ID: 18653253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotalol in treatment of pediatric cardiac arrhythmias.
    Celiker A; Ayabakan C; Ozer S; Ozme S
    Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
    Hohnloser SH
    Am J Cardiol; 1997 Oct; 80(8A):82G-89G. PubMed ID: 9354415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experience with intravenous sotalol in children with and without congenital heart disease.
    Valdés SO; Miyake CY; Niu MC; de la Uz CM; Asaki SY; Landstrom AP; Schneider AE; Rusin CG; Patel R; Lam WW; Kim JJ
    Heart Rhythm; 2018 Dec; 15(12):1862-1869. PubMed ID: 30003959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical safety profile of sotalol in patients with arrhythmias.
    Soyka LF; Wirtz C; Spangenberg RB
    Am J Cardiol; 1990 Jan; 65(2):74A-81A; discussion 82A-83A. PubMed ID: 2403737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
    Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
    Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.